Comprehensive Guide to GLP-1 Agonists in Research: Semaglutide, Tirzepatide & More

scienceApr 2, 20262 min read

By KeoSupps Research Team

Introduction

GLP-1 (Glucagon-Like Peptide-1) receptor agonists represent one of the most extensively researched classes of peptides in metabolic science. Originally studied for diabetes research, these compounds have expanded into areas of obesity, cardiovascular protection, and neuroprotection research.

GLP-1 Receptor Agonist Comparison Chart

Peptide	Half-Life	Bioavailability	Primary Research Uses	Typical Dosing Protocol
Semaglutide	165-184 hours	89% (subcutaneous)	Metabolic research, neuroprotection	0.25-2.4mg weekly
Tirzepatide	120+ hours	80% (subcutaneous)	Dual GIP/GLP-1 research	0.25-15mg weekly
Liraglutide	13 hours	55% (subcutaneous)	Short-term metabolic studies	0.6-3.0mg daily
Exenatide	2.4 hours	65% (subcutaneous)	Acute response studies	5-10mcg twice daily

Research Applications Matrix

Application	Semaglutide	Tirzepatide	Liraglutide	Evidence Level
Metabolic Disorders	✓ High	✓ Highest	✓ High	Level A
Cardiovascular Protection	✓ High	✓ Moderate	✓ High	Level A
Neuroprotection	✓ High	✓ Low	✓ Moderate	Level B

Research Disclaimer: This information is provided for educational and research purposes only.

Explore Related Research Paths

Browse All Research Compounds

Explore the full catalog of peptides, GLP-1 compounds, and supporting products.

GLP-1 and Weight Loss

View GLP-1 focused compounds for metabolism and appetite pathway research.

Read Storage and Handling FAQ

Review storage, stability, and shipping guidance before ordering.

Ready to start your peptide journey?

Explore our complete selection of pharmaceutical-grade peptides trusted by thousands.

Shop Now

science

BPC-157 vs TB-500: Which Peptide is Right for Your Research?

A deep-dive comparison of BPC-157 and TB-500 — two of the most studied healing peptides in modern research. Understand their mechanisms, synergies, and how researchers are combining them.

3/25/2026